Phase 3 Study of the Biologic Lung Volume Reduction (BLVR) System in Advanced Upper Lobe Predominant (ULP) Emphysema

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00716053
Recruitment Status : Withdrawn
First Posted : July 16, 2008
Last Update Posted : January 18, 2010
Information provided by:
Aeris Therapeutics